(Q48105258)

8 February 2018

title

Neurotoxic effects of berberine on long-term L-DOPA administration in 6-hydroxydopamine-lesioned rat model of Parkinson's disease (English)

1 reference

8 February 2018

1 reference

1 reference

Keon Sung Shin

1

1 reference

8 February 2018

Hyun Sook Choi

2

1 reference

8 February 2018

Ting Ting Zhao

3

1 reference

8 February 2018

Kwang Hoon Suh

4

1 reference

8 February 2018

Ik Hyun Kwon

5

1 reference

8 February 2018

Soon Ok Choi

6

1 reference

8 February 2018

Myung Koo Lee

7

1 reference

8 February 2018

publication date

29 March 2013

1 reference

8 February 2018

Archives of Pharmacal Research

published in

1 reference

8 February 2018

volume

36

1 reference

8 February 2018

issue

6

1 reference

8 February 2018

page(s)

759-767

1 reference

8 February 2018

https://scigraph.springernature.com/pub.10.1007/s12272-013-0051-4

exact match

0 references

cites work

Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Plastic effects of L-DOPA treatment in the basal ganglia and their relevance to the development of dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Acupuncture attenuates repeated nicotine-induced behavioral sensitization and c-Fos expression in the nucleus accumbens and striatum of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Biogenic amine-aldehyde condensation products: tetrahydroisoquinolines and tryptolines (beta-carbolines).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Neostriatal enkephalin-immunoreactive neurones project to the globus pallidus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Ageing and Parkinson's disease: substantia nigra regional selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

CYP2D plays a major role in berberine metabolism in liver of mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Effect of trihexyphenidyl, a non-selective antimuscarinic drug, on decarboxylation of L-dopa in hemi-Parkinson rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Berberine induces apoptosis through a mitochondrial/caspase pathway in human promonocytic U937 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Effects of hydrastine derivatives on dopamine biosynthesis in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Inhibition of dopamine biosynthesis by tetrahydropapaveroline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Effects of berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Aggravation of l-DOPA-induced neurotoxicity by tetrahydropapaveroline in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine produce akinesia, rigidity, tremor and cognitive deficits in middle-aged rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Potential bioactivated neurotoxicants, N-methylated beta-carbolinium ions, are present in human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Isoquinoline neurotoxins in the brain and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Levodopa-induced dyskinesia: review, observations, and speculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Anxiolytic effect of berberine on exploratory activity of the mouse in two experimental anxiety models: interaction with drugs acting at 5-HT receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Harman (1-methyl-beta-carboline) is a natural inhibitor of monoamine oxidase type A in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Inhibitory effects of bulbocapnine on dopamine biosynthesis in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Kinetic difference of berberine between hippocampus and plasma in rat after intravenous administration of Coptidis rhizoma extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Edaravone neuroprotection effected by suppressing the gene expression of the Fas signal pathway following transient focal ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Effects of harman and norharman on dopamine biosynthesis and L-DOPA-induced cytotoxicity in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Enantio-selective inhibition of (1R,9S)- and (1S,9R)-beta-hydrastines on dopamine biosynthesis in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

Neuroprotective effects of berberine on stroke models in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0051-4

10.1007/S12272-013-0051-4

21 January 2018

Identifiers

DOI

1 reference

8 February 2018

1 reference

8 February 2018